Altruista Health Announces Pulse8 to License CDPS Predictive Risk Adjustment System

Reston, VA (PRWEB) December 17, 2015

Altruista Health, Inc., an innovative provider of population health management technology solutions for health plans and health care providers, announced today that Pulse8 has agreed to license the Chronic Illness and Disability Payment System (CDPS), a predictive risk adjustment and classification system. Altruista Health is the exclusive commercial-use licensor of CDPS, which was developed by the University of California, San Diego to calculate risk-adjusted payments for Medicaid populations.

Based in Annapolis, Maryland, Pulse8 is an innovative healthcare analytics company that provides transparent and flexible business intelligence (BI) tools and analytic solutions to healthcare payers and at-risk providers. Utilizing a targeted blend of risk adjustment and quality analytics, predictive modeling, dynamic intervention planning, and other data analytics tools, Pulse8 offers real-time visibility into member and provider activities so clients can apply interventions that have the highest impact on quality and financial outcomes.

According to Pulse8 CEO John Criswell, CDPS will augment the financial precision of the company's risk adjustment analytics for Medicaid, Medicare Advantage, and Commercial health exchange markets.

"CDPS is highly revered for its accuracy, particularly among populations with chronic conditions and other complex care needs," said Criswell. "We're excited to help our clients realize the quality and cost-savings advantages CDPS can help them achieve."

About CDPS
The Chronic Illness and Disability Payment System (CDPS) is a diagnostic- and pharmacy-based risk adjustment model and classification system that supports health status-based capitated payments for Medicaid and Medicare populations. CDPS was first developed in 2000 by the University of California, San Diego (UCSD), and has been updated and enhanced several times since then. Currently, CDPS analyzes and stratifies populations across 58 risk categories based on disease type or body system, as well as 15 pharmacotherapy-based conditions. In 2007, Altruista Health partnered with UCSD to integrate CDPS into the GuidingCare Care Management platform. Altruista Health remains the exclusive licensor of the CDPS, MRX and CDPS + Rx predictive models for use in commercial applications.

About Altruista Health
Headquartered in the Washington D.C. area, Altruista Health is an innovative provider of care management technology solutions that address the complex care and support needs of Medicaid, long-term care and other special needs populations. The company has rapidly become an industry leader; the Gartner Group has identified Altruista Health as one of the fastest growing care management technology companies in the government sector. More than 30 organizations operating across 33 states use our solutions each day to streamline clinical and administrative processes, improve patient outcomes and reduce avoidable healthcare costs. For more information, visit http://www.altruistahealth.com

About Pulse8
Pulse8 is the only Healthcare Analytics and Technology Company delivering complete visibility into the efficacy of your Risk Adjustment and Quality Management programs. We enable health plans and at-risk providers to achieve the greatest financial impact in the Health Insurance Exchange (HIX), Medicare Advantage, and Medicaid markets. By combining advanced analytic methodologies with extensive health plan experience, Pulse8 has developed a suite of uniquely pragmatic solutions that are revolutionizing risk adjustment. Pulse8's flexible business intelligence tools offer real-time visibility into member and provider activities so our clients can apply the most cost-effective and appropriate interventions for closing gaps in documentation, coding, and quality. For more company information, please contact Scott Filiault at (732) 570-9095, Scott.Filiault(at)Pulse8.com, visit us at http://www.Pulse8.com, or follow us on Twitter @Pulse8News.

Read the full story at http://www.prweb.com/releases/2015/12/prweb13134651.htm